Live Breaking News & Updates on Ibezapolstat Phase|Page 3

Stay updated with breaking news from Ibezapolstat phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences

Three scientific posters highlighting novel anti-virulence pharmacologic properties of oral ibezapolstat for C. difficile Infection; effects on toxin production, biofilm and the gut microbiomeA. ....

United States , Kevin Garey , Michael Silverman , Jinhee Jo , Robertj Deluccia , Eugenie Basseres , Society Or Healthcare Epidemiology Of America , Drug Administration , University Of Houston , Acurx Pharmaceuticals Inc , Medicine Association , Infectious Diseases Society Of America , Data Monitoring Committee , Company Ph , International Conference On Molecular Biology , Pediatric Infectious Diseases Society , Trial Oversight Committee , University Of Houston College Pharmacy , Society For Healthcare Epidemiology Of America , Infectious Disease Society Of America Idsa Idweek , Exchange Commission On Form , Acurx Pharmaceuticals , Society Of Infectious Diseases Pharmacists , Exchange Commission , School Of Pharmacy , New Class ,

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers OpGen, Inc. (NASDAQ:OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received . ....

Kontron America , Hormel Foods Corporation , Acurx Pharmaceuticals Inc , Opgen Inc , Inmode Ltd , Biosystems Inc , Phio Pharmaceuticals , Lifesciences Inc , International Conference On Molecular , Systems Inc , Tango Therapeutics Inc , Aditxt Inc , Supercom Ltd , Edesa Biotech Inc , Shengfeng Development Limited , Ll Flooring Holdings Inc , Atreca Inc , Biocept Inc , Medicx Health , Secoo Holding Limited , Logicmark Inc , Infosys Limited , Taoping Inc , National Cinemedia Inc , Glucotrack Inc , Genetron Holdings Limited ,

What's Going On With Acurx Pharmaceuticals Stock? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares surged Monday. ....

Robertj Deluccia , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Ibezapolstat Phase , Last Monday , Executive Chairman ,

Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection

Based on observed aggregate blinded data the Company has determined that both treatments, ibezapolstat and the control antibiotic vancomycin, have performed as. ....

United States , Davidp Luci , Robertj Deluccia , Data Monitoring Committee , Infectious Diseases Society Of America , Society For Healthcare Epidemiology Of America , Trial Oversight Committee , Drug Administration , Prnewswire Acurx Pharmaceuticals Inc , Company Annual Report On Form , Acurx Pharmaceuticals , Exchange Commission , Acurx Pharmaceuticals Inc , Clinical Cure , Fast Track Designated , Independent Data Monitoring Committee , Executive Chairman , Chief Executive Officer , Ibezapolstat Phase , Bile Acid , Clinical Practice Guidelines , Infectious Diseases Society , Healthcare Epidemiology , New England Journal , Private Securities Litigation Reform Act , Qualified Infectious Disease Product ,

Acurx Announces Presentation and Update of Its pol IIIC R&D Pipeline at the World Antimicrobial Resistance Scientific Congress

Ibezapolstat is currently enrolling in a Phase 2b trial for C. difficile infection in U.S. centers across the country and nearing its goal to reach a targeted. ....

United States , Robertj Deluccia , Data Monitoring Committee , Company Ph , Society Or Healthcare Epidemiology Of America , Acurx Pharmaceuticals Inc , Exchange Commission , Trial Oversight Committee , World Antimicrobial Resistance Congress , Exchange Commission On Form , Drug Administration , Acurx Pharmaceuticals , Prnewswire Acurx Pharmaceuticals Inc , World Antimicrobial Resistance Scientific Congress On , Infectious Diseases Society Of America , Interim Analysis , Independent Data Monitoring , Lead Optimization , Acute Bacterial Skin , Skin Structure Infections , Acurx Executive Chairman , Innovation Showcase , Independent Data Monitoring Committee , Gram Positive Selective Spectrum , Investigational New Drug Application , Qualified Infectious Disease Product ,